AJ Lanigan: Certainly. In Actual fact, pharma businesses are creating big revenue with treatment options like Keytruda and Opdivo that offer with PD-1 and PD-L1. Here’s the super interesting component: visualize checkpoints as site visitors signals. You don’t want an immune system that’s jogging wild like a freight coach around waiting for link from Social Bookmarking (4)